Close Menu

R&D, Ruh-Roh

Pharmaceutical companies are watching their R&D costs go up, up, up, as they search for the next blockbuster drug amid dried-up pipelines and upcoming patent cliffs, reports The Guardian's Julia Kollewe. A recent Deloitte report shows that the cost of bringing a drug to market for the world's 12 biggest pharma companies has risen by more than 25 percent to about $1 billion this year from about $830 million in 2010, Kollewe says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.